Bio4Dreams
Bio4Dreams is a privately certified incubator established in 2017 and based in Milan, Italy. It is dedicated to supporting very early-stage innovative startups in the life sciences sector. The organization assists exceptional individuals in leveraging their scientific research to develop sustainable and pragmatic business models with a global outlook. Bio4Dreams distinguishes itself by following the entire development process of individual projects, starting from their inception. It integrates various players in the innovation ecosystem, fostering a collaborative environment that extends beyond traditional incubation practices. The incubator offers fully customized and flexible incubation programs, employing validated methodologies to enhance the potential for success. With its international focus, Bio4Dreams provides startups with the opportunity to compete effectively on a global scale, positioning itself as a pivotal reference point for entrepreneurial ideas in life sciences.
Top Stages
4 past transactions
Euleria
Seed Round in 2022
Euleria is a company specializing in digital rehabilitation devices and patient recovery solutions. It develops innovative medical technologies that facilitate rehabilitation both on-site and remotely. The company's platform offers exercise therapy tailored for patients undergoing rehabilitation, allowing them to complete programs in various settings, including clinics and their homes. Euleria also provides an online portal for patients to connect with professionals, enabling movement specialists to monitor progress and support individuals throughout their healing journey. By focusing on measurable and accessible rehabilitation, Euleria aims to enhance the recovery experience for both patients and healthcare providers.
BrainDTech
Series B in 2020
BrainDTech is a company focused on the early diagnosis and monitoring of neurological and neurodegenerative diseases through innovative liquid biopsy technology. Utilizing a patented method, the company analyzes miRNA derived from microglial microvesicles to provide accurate diagnosis, prognosis, and treatment monitoring for various brain conditions. This platform allows healthcare professionals to predict the onset of brain diseases before symptoms manifest, enhancing the potential for timely intervention and improved patient outcomes. By concentrating on both neurodegenerative and inflammatory diseases, BrainDTech aims to advance the field of neurology with its cutting-edge diagnostic solutions.
BrainDTech
Series B in 2018
BrainDTech is a company focused on the early diagnosis and monitoring of neurological and neurodegenerative diseases through innovative liquid biopsy technology. Utilizing a patented method, the company analyzes miRNA derived from microglial microvesicles to provide accurate diagnosis, prognosis, and treatment monitoring for various brain conditions. This platform allows healthcare professionals to predict the onset of brain diseases before symptoms manifest, enhancing the potential for timely intervention and improved patient outcomes. By concentrating on both neurodegenerative and inflammatory diseases, BrainDTech aims to advance the field of neurology with its cutting-edge diagnostic solutions.
BrainDTech
Series A in 2017
BrainDTech is a company focused on the early diagnosis and monitoring of neurological and neurodegenerative diseases through innovative liquid biopsy technology. Utilizing a patented method, the company analyzes miRNA derived from microglial microvesicles to provide accurate diagnosis, prognosis, and treatment monitoring for various brain conditions. This platform allows healthcare professionals to predict the onset of brain diseases before symptoms manifest, enhancing the potential for timely intervention and improved patient outcomes. By concentrating on both neurodegenerative and inflammatory diseases, BrainDTech aims to advance the field of neurology with its cutting-edge diagnostic solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.